MRNA a medical Technology Stock LONG MRNA is a medical technology company. It is in the vaccine sector and competes ( well) with
NVAX and PFE among others. Earnings are upcoming on 8/3 in about a week.
On the 30 minute chart it appears to be in a descending wedge pattern which is typically
a bottoming with a breakout over and beyond the descending trendline. The relative
trend indicator shows the downtrend to be a slow grinding type trend with some minor
corrections along the way. As might be expected the RS lines are low in the indicator's
channel. I see this as a setup for a pre-earnings play with the expectation that MRNA
could breakout above the resistance trend line and move toward the horizontal resistance
of the triple top earlier in mid-July. I see medical stocks as a good alternative to technology
stocks that may be overextended and stressed by the current financial chaos pressuring
the markets. Another approach is a two call options targeting $ 125 expiring 8/11
and running the first until 100% profit or 8/2, the day before the expiration whichever
comes first and letting the other run through earnings into the middle of the following
week at 8/9. I always like to cut these short of expiration by a few days to diminish the
effects of time decay.
MRNA trade ideas
$MRNA - Possible ReversalNASDAQ:MRNA Is basing inside descending broadening wedge and starting to break out.
Both RSI and MACD is displaying bullish divergence. $126 - $127 is POC resistance and breaking above that area will be bullish.
Notice that the stock is in Stage 1 bottoming process. So it has a lot of room to run. I will be building a position in the coming week.
Targets - $160, $180, $210
Risk - $100, $60
If you like this tweet, don't forget to follow, like and retweet.
MRNA // Falling Wedge at DailyHello Folks,
We can see Falling Wedge pattern clearly at MRNA with RSI positive divergence.
I consider it important that this image is formed at a significant level of horizontal support.
As a condition to enter the position, it would be reasonable to wait for the formation of a new high.
Downtrend Continuation for $MRNA :-)The hype of elixir ability of mRNA vaccines by Moderna has reached a peak in Aug 2021
Price reached as high as 500 dollar.
But it turns negative after that.
after a massive plunge, price has been consolidating between 118 - 208 for more than 1.5 years, it looks like price has been hovering around 118 to go lower.
If the downtrend continues after the consolidation, chances are high that in the next 1.5 years or so, price will fall back between 50 - 80
I am prone towards more downside, although i could be wrong
This is just my own research and should never be construed as buy or sell call
MODERNA $305 | Bidding at $220 and $150 Informed Players and speculators at Sub $100 levels are booking gains
we wait for additional drwadowns and re accomodation ACCUMULATION of designated Bankers for the next run up OR cycle
Vaccine COViD was intense HiV was the sell on News..
we await next Drama and Biden Policy on Healthcare etc..
for now Watch or Chrun at key leves (eyeball the box)
Profits Over Patients: The Morally Complex Realm of Big PharmaThis strategy dissects the dual nature of big pharmaceutical firms like Johnson & Johnson, Pfizer, Moderna, and Merck & Co viewed through base Fibonacci Extension Clustering. Despite big pharma's significant contributions to healthcare, these firms have benefited from questionable practices, including price manipulation and exploiting addictions . Price manipulation is a notorious strategy where companies arbitrarily hike drug prices, often without any significant improvements in their efficacy.
"Big Pharma" has faced backlash for allegedly contributing to the opioid crisis . By aggressively marketing highly addictive pain medications , they may have exacerbated a public health catastrophe, leading to thousands of deaths annually.
Such practices illuminate the immoral landscape of the pharmaceutical industry. While these firms play a vital role in global healthcare, their business tactics often prioritize profits over patients, demanding a closer scrutiny of this sector's ethics.
1. Johnson & Johnson (JNJ): Around $440 billion
2. Pfizer Inc. (PFE): Around $240 billion
3. Moderna Inc. (MRNA): Around $110 billion
4. Merck & Co., Inc. (MRK): Around $200 billion
TOTAL = 1 Trillion
MRNA Short with resistance at 145.50I plan a short trade ( NASDAQ:MRNA ) at 144.41. The entry is just before the resistance zone at ~145.50 which is also confirmed by the Fibonacci 0.5 level. At 146.69 is the stop loss placed so that there is enough space to breathe. The take profit is very conservatively placed at a risk-reward ratio of 1:1.
MRNA ? Buy Weakness MRNA descended this past winter off a head-and-shoulders pattern on the daily chart just under
the demand zone as shown by the LuxAlgo indicator. Price is now in a downtrend heading into
earnings tomorrow. MRNA needs to show something good otherwise it will break through the
demand zone and keep going down.
This is a risky earnings play betting that something will show up on the report to buoy up the
company and its stock. I will risk 0.01% of the trading account on a call option with DTE 5/19/23
looking for a minor surge and so a good quick profit.
( see also the link below)
Moderna Very Bearish (Pt 2)Part 1:
The136.50 target was hit and Moderna is now resting at a critical neckline area which bulls have defended for quite some time. I expect a small bounce here but ultimately, a break of this level and a spill much lower. View of the weekly chart below:
This is a head and shoulders within a head & shoulders playing out. It would be invalidated if MRNA can retake the 20 weekly moving average (165.32) and flip it to support.
Bearish price target: 73USD!
Moderna to 136.50I will be looking for a short tomorrow on any bounce.
Bearish marubozo daily candle with a rejection of the 200DMA, cutting through the 50DMA(green) then 20DMA(yellow) like butter and on monster volume. Not good! High probability of downside continuation tomorrow & the 20 + 50 DMAs will now flip from support to resistance.
Downside price target: Major area of support/confluence at 136.50.
While this is in my opinion the most probable scenario, let's scenario cast a few others:
Potential bullish scenarios (neither which is likely to me!)
1.) A gap-up tomorrow then tight trading range day creating a bullish harami.
2.) Further initial continuation tomorrow followed by bulls pushing back hard creating either a hammer or pinbar daily candle signaling a potential bounce to the 2 major moving average resistances.